C5N-20727-24052
1 vaccination
5 coded responses
5 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 114 / NY
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-18
Registered in v-safe
-
2021-04-18
Survey response — day 7, dose 1MedDRA: Dyspnoea, Rash, Urticaria — Feeling: Poor · Fever · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: labored breathing, hives/eruptions throughout body - left arm, legs, face.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — day 14, dose 1MedDRA: Dyspnoea, Hypersensitivity, Mass, Rash, Swelling, Urticaria — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Hives short breath swelling on neck upper back shoulders rashes on knees on feet right buttocks left arm lumpiness in sides of breasrs armpits · Healthcare visit (other): Allergist as suggested by vaccine siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-17
Survey response — day 35, dose 1MedDRA: Anaphylactic shock, Emergency care, Lymphadenopathy, Urticaria — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Hives, anaphalactic shock, emercency visit. Lymph nodes swelling.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Report sent to call center — day 35, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-23
Survey response — day 42, dose 1MedDRA: Chest pain, Dyspnoea, Pruritus, Specialist consultation, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Hives labored breathing itching on fingers under feet chest pains. No response from fda cdc no one. Heard of 5 cases from the people themselves. But i jave to work to live.pain is severe · Healthcare visit (other): AllergistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-23
Report sent to call center — day 42, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-11
Survey response — 3 months, dose 1MedDRA: Headache, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Runny nose headaches to poont of passing outMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-11
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech |
Call center
4 call center cases
4 unsuccessful
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): labored breathing, hives/eruptions throughout body - left arm, legs, face.
Release 7 — day 14, dose 1
Symptoms: Hives short breath swelling on neck upper back shoulders rashes on knees on feet right buttocks left arm lumpiness in sides of breasrs armpits
Healthcare visit (other): Allergist as suggested by vaccine site
Release 8 — day 35, dose 1
Symptoms: Hives, anaphalactic shock, emercency visit. Lymph nodes swelling.
Release 8 — day 42, dose 1
Symptoms: Hives labored breathing itching on fingers under feet chest pains. No response from fda cdc no one. Heard of 5 cases from the people themselves. But i jave to work to live.pain is severe
Healthcare visit (other): Allergist
Release 9 — 3 months, dose 1
Symptoms: Runny nose headaches to poont of passing out
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hypersensitivity | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Anaphylactic shock | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Mass | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Swelling | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release